HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic rhabdomyosarcoma in an adult: a rare primary malignant liver tumor. Case report and literature review.

Abstract
Rhabdomyosarcomas are malignant tumors that display features of striated muscle differentiation. They are the most common soft-tissue sarcomas among children and young adults. In mature adults however there are very rare. The liver as a primary site in adults has only been described in 12 cases. We report a case of a primary alveolar rhabdomyosarcoma of the liver in a 59 year old female, confirmed by histological examination using immunohistochemical analysis (positive actin, desmin, vimentin and myogenin staining) and fluorescent in situ hybridization (FISH) analysis (positivity for PAX3/FOXO1A fusion). The patient underwent primary surgical resection, but presented a few weeks after surgery already with recurrent disease in the abdomen and bone metastasis. Despite initial good response to chemotherapy (doxorubicin/ifosfamide) and stable disease at 12 months after diagnosis, the patient died 31 months after the first presentation secondary to complicated abundant abdominal recurrent disease. We further present a review of the literature on published similar cases since 1979.
AuthorsG Schoofs, L Braeye, R Vanheste, G Verswijvel, M Debiec-Rychter, R Sciot
JournalActa gastro-enterologica Belgica (Acta Gastroenterol Belg) Vol. 74 Issue 4 Pg. 576-81 (Dec 2011) ISSN: 1784-3227 [Print] Belgium
PMID22319971 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Liver Neoplasms (drug therapy, metabolism, pathology, surgery)
  • Magnetic Resonance Imaging
  • Middle Aged
  • Rhabdomyosarcoma, Alveolar (drug therapy, metabolism, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: